Ai Alphabet F - Search News

Alphabet, Isomorphic and AI

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

The Wall Street Journal on MSN · 2d

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

New York Post on MSN · 1d

Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue on its mission to create new drugs and medicines using AI.

Alphabet: Leading The AI Race

Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...

Yahoo Finance3d

Is a New AI Model the Catalyst Alphabet Stock Needed?

Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question its position in the artificial intelligence (AI) landscape ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Alphabet, Isomorphic and AI

Trending now